NEW HAVEN, Conn.--(BUSINESS WIRE)--Veradermics, Incorporated, a dermatologist-founded, late clinical-stage biopharmaceutical company developing potentially first-in-class therapeutics for common ...
Biologists achieved a landmark in protein design last year: using artificial intelligence (AI) to draw up entirely new antibody molecules 1. Yet the proof-of-principle designs lacked the potency and ...
Abstract: The increasing popularity of earable devices stimulates great academic interest to design novel head gesture-based interaction technologies. But existing works simply consider it as a ...